Neurobiology of Stress is an esteemed open-access journal dedicated to advancing the field of stress research, published by ELSEVIER SCIENCE INC. Since its inception in 2015, the journal has rapidly ascended in academic prestige, achieving a remarkable Q1 ranking across multiple categories, including Biochemistry, Cellular and Molecular Neuroscience, and Endocrinology, among others. With an impact-driven approach, it focuses on the intricate mechanisms of stress response at molecular, cellular, and systemic levels, making it an essential resource for researchers, professionals, and students alike. The journal fosters interdisciplinary collaboration and innovation, providing a platform for cutting-edge studies and critical reviews that address the complexities of stress biology. As part of its commitment to accessibility, all published articles are freely available, ensuring that groundbreaking findings reach a global audience. Join a community at the forefront of stress research and contribute to the vital conversations shaping our understanding of neurobiological processes.

MOLECULAR PSYCHIATRY, published by SpringerNature, is a premier peer-reviewed journal that has established itself as a leading platform for the dissemination of cutting-edge research in the fields of neuroscience, molecular biology, and psychiatry. With an impressive impact factor and a reputation for excellence, the journal is ranked Q1 in key categories, signifying its high academic quality and relevance. The journal’s scope spans groundbreaking studies and innovative therapeutic approaches that intersect at the molecular and cellular levels, providing invaluable insights into the biological underpinnings of psychiatric disorders. Since its inception in 1996, MOLECULAR PSYCHIATRY has evolved to support both established and emerging researchers, fostering a collaborative environment that enhances the understanding of mental health. It is committed to improving access to scientific knowledge, although it currently does not offer open access options. With its headquarters in London, the journal continues to play a pivotal role in enhancing the global dialogue on psychiatric and neurological advancements, making it an essential resource for academics and professionals dedicated to advancing mental health sciences.

Schizophrenia Research is a premier academic journal focused on innovative research within the domain of psychiatry and mental health, published by Elsevier. With its ISSN 0920-9964 and E-ISSN 1573-2509, the journal has established a strong presence since its inception in 1988, evolving to publish cutting-edge findings up to 2024. Positioned in Q1 in Psychiatry and Mental Health and Q2 in Biological Psychiatry, it ranks impressively in the 83rd percentile among its peers, according to Scopus, ranking #93/567 in the field of Medicine, and #12/51 in Neuroscience. This journal serves as a vital platform for the dissemination of significant scientific advancements and theoretical insights into schizophrenia, fostering a deeper understanding of mental illnesses. Although it operates on a subscription basis, its critical role in informing both ongoing research and clinical practices cannot be overstated, making it an essential resource for researchers, clinicians, and students alike. Join a global community dedicated to improving mental health outcomes and advancing the study of schizophrenia through this reputable publication.

ADDICTION BIOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to advancing the understanding of addiction science. With an impressive impact factor and recognized as a Q1 journal in Medicine, Pharmacology, and Psychiatry and Mental Health, ADDICTION BIOLOGY occupies a crucial position in the scientific discourse surrounding the biological and neurochemical underpinnings of addictive behaviors. Since its inception in 1996, the journal has been at the forefront of research, fostering interdisciplinary collaborations and promoting innovative studies that explore the complexities of addiction. Researchers and professionals benefit from the journal's commitment to high-quality manuscripts, offering essential insights into prevention, treatment, and rehabilitation strategies for substance use disorders. Although it does not offer open access, ADDICTION BIOLOGY remains accessible through various academic libraries, ensuring that groundbreaking studies reach a global audience. This journal is indispensable for anyone seeking to deepen their knowledge in the rapidly evolving field of addiction research.

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging is a leading interdisciplinary journal published by Elsevier, focusing on the convergence of biological psychiatry, cognitive neuroscience, and advanced neuroimaging techniques. With its prestigious Q1 rankings across essential categories such as Biological Psychiatry, Cognitive Neuroscience, and Neurology (clinical), this journal is at the forefront of research that examines the complexities of mental health through innovative methodologies. Covering a broad spectrum of topics from neurobiological mechanisms to clinical applications, it aims to provide a platform for scholars and practitioners to exchange insights on mental disorders and their neurobiological underpinnings. The impact factor and Scopus rankings further underscore its importance, with rankings highlighting its position in the top percentiles of related disciplines. By fostering an open exchange of ideas and promoting cutting-edge research, this journal is an essential resource for researchers, professionals, and students dedicated to advancements in the understanding and treatment of psychiatric and neurological conditions.

NEUROIMAGE, published by Academic Press Inc Elsevier Science, is a leading international journal dedicated to advancing the fields of cognitive neuroscience and neurology. With an impressive impact factor that places it in the Q1 category for both disciplines, NEUROIMAGE stands at the forefront of disseminating high-quality research that employs advanced imaging methods to elucidate the workings of the human brain. As a pivotal platform since its inception in 1992, this journal has continued to thrive, embracing Open Access publishing since 2020 to ensure wider dissemination and accessibility of cutting-edge findings. With a Scopus rank of 7th in cognitive neuroscience and 13th in neurology, and situated in the 94th and 93rd percentiles respectively, NEUROIMAGE serves as an invaluable resource for researchers, professionals, and students alike seeking to explore the intricate relationships between brain structure and function. For more information, please visit their office at 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495.

NEUROSCIENCE RESEARCH, published by Elsevier Ireland Ltd, is a leading journal in the field of neuroscience, with a notable reputation for disseminating high-quality research that spans a variety of topics within the discipline. With an ISSN of 0168-0102 and an E-ISSN of 1872-8111, this journal serves as a vital platform for both established researchers and emerging voices in the field. Ranking in the Q2 quartile in both Medicine and Neuroscience categories, it has been recognized as a reliable source of innovative findings since its inception in 1984, with continuous publication through 2024. Although it does not currently offer Open Access options, the journal is indexed in Scopus, holding a significant position at Rank #48/113 in General Neuroscience, reflecting its contribution to advancing the understanding of neural mechanisms across various contexts. With its address anchored in Ireland, NEUROSCIENCE RESEARCH plays an essential role in bridging scientific inquiry and practical applications, making it an indispensable resource for researchers, professionals, and students dedicated to the burgeoning field of neuroscience.

NEUROENDOCRINOLOGY LETTERS is a distinguished academic journal published by MAGHIRA & MAAS PUBLICATIONS, focusing on the intricate interplay between the nervous system and the endocrine system. Since its inception in 1979, the journal has provided a vital platform for researchers and practitioners in the fields of endocrinology, psychiatry, and neurology, making significant contributions to our understanding of neuroendocrine mechanisms and their clinical implications. Although currently categorized in the Q4 quartile across several disciplines, including Endocrine and Autonomic Systems and Neurology, the journal continues to strive for excellence in disseminating quality research. With an ISSN of 0172-780X and E-ISSN 2354-4716, it allows for global engagement, albeit not currently available as Open Access. The journal's impact on its respective fields is underscored by its steady publication trajectory from its initial years to 2024, making it an essential resource for students, professionals, and researchers seeking to explore the dynamic relationships within neuroendocrinology.

Brain Behavior & Immunity-Health is a pioneering journal dedicated to advancing knowledge in the fields of nephrology and psychiatry, with a specific focus on the interplay between brain health and immune function. Published by Elsevier, this journal holds a prestigious Q1 ranking in both nephrology and psychiatry and mental health, underscoring its reputation for excellence within a competitive academic landscape. With an ISSN of 2666-3546, it provides a vital platform for researchers and professionals to disseminate cutting-edge findings and explore novel approaches to understanding the complex interactions between mental health and physical health dimensions. Available to readers in the United States and internationally, the journal not only supports open dialogue among scholars but also aims to foster interdisciplinary collaborations that address the critical challenges in these fields. As a part of its objectives, Brain Behavior & Immunity-Health is committed to highlighting transformative research that can lead to innovative strategies for healthcare, making it an essential resource for anyone seeking to expand their expertise in the intersection of behavioral health and immunology.

PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES, published by Routledge Journals, Taylor & Francis Ltd, is a pivotal journal in the field of psychiatry, focusing on the intricate interplay between interpersonal relationships and biological factors in mental health. Established in 1938, the journal has cultivated a rich legacy of scholarship, with a projected convergence of research extending to 2024. With an impact that resonates through its Q2 ranking in Medicine (miscellaneous) and Q3 in Psychiatry and Mental Health as of 2023, it ranks 325th among 567 in its category on Scopus, highlighting its relevance and reach within the academic landscape. While it is not an open-access journal, it serves a vital role in disseminating cutting-edge research, encouraging multidisciplinary dialogue among researchers, clinicians, and students alike. The journal’s dedication to exploring complex psychiatric issues makes it an indispensable resource for advancing knowledge and enhancing clinical practice in mental health.